Myriad Genetics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1995
Net Income	-263.3	-112	-27.2	-199.5	4.6	133.3	17.4	117.2	80.2	176.2	Upgrade
Depreciation & Amortization	73.2	64.4	75.6	72	73	54.4	48.3	26.8	25	13.8	Upgrade
Share-Based Compensation	40.7	38.1	36.3	25.2	33.5	27.1	29.9	31.6	42.3	16	Upgrade
Other Operating Activities	38.5	-96.8	-66.1	163	-27.4	-98.9	10.6	-9.3	-7	-15.8	Upgrade
Operating Cash Flow	-110.9	-106.3	18.6	60.7	83.7	115.9	106.2	166.3	140.5	190.2	Upgrade
Operating Cash Flow Growth	-	-	-69.36%	-27.48%	-27.78%	9.13%	-36.14%	18.36%	-26.13%	9.37%	Upgrade
Capital Expenditures	-73.3	-45.3	-18	-10.2	-8.6	-8.4	-6.1	-5	-23.9	-14.3	Upgrade
Acquisitions	0	-57.2	379.1	21.3	-278.5	0	-216.1	-37	-20.1	-223.5	Upgrade
Change in Investments	105.2	25	-86.7	8.2	0.7	-3.2	75.9	-49.4	84.9	220.7	Upgrade
Investing Cash Flow	31.9	-77.5	274.4	19.3	-286.4	-11.6	-146.3	-91.4	40.9	-17.1	Upgrade
Share Issuance / Repurchase	123.6	6.3	91.8	13.3	-26.8	45.3	-25.6	-68.3	-180.7	-222.9	Upgrade
Debt Issued / Paid	38.1	-0.7	-227.6	-9.6	223.6	-90	97.4	0	0	0	Upgrade
Other Financing Activities	-8.8	-13.6	-14.8	-13.7	-14.5	-50.3	-	-	3.4	11.1	Upgrade
Financing Cash Flow	152.9	-8	-150.6	-10	182.3	-95	71.8	-68.3	-177.3	-211.8	Upgrade
Exchange Rate Effect	0.6	-0.6	-0.6	0.5	2.7	-0.8	2.2	-2.2	-4.8	-0.6	Upgrade
Net Cash Flow	74.5	-192.4	141.8	70.5	-17.7	8.5	33.9	4.4	-0.7	-39.3	Upgrade
Free Cash Flow	-184.2	-151.6	0.6	50.5	75.1	107.5	100.1	161.3	116.6	175.9	Upgrade
Free Cash Flow Growth	-	-	-98.81%	-32.76%	-30.14%	7.39%	-37.94%	38.34%	-33.71%	8.25%	Upgrade
Free Cash Flow Margin	-24.46%	-22.35%	0.09%	7.91%	8.82%	14.45%	13.74%	21.78%	16.13%	22.60%	Upgrade
Free Cash Flow Per Share	-2.23	-1.88	0.01	0.68	1.02	1.55	1.47	2.30	1.64	2.32	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).